Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

Ravinder Anand-Ivella School of Biosciences, University of Nottingham, Sutton Bonington, UKView further author information

Kee Henga School of Biosciences, University of Nottingham, Sutton Bonington, UKView further author information

Leen Antoniob Department of Chronic Diseases and Metabolism, Laboratory of Clinical and Experimental Endocrinology, Leuven, KU, Belgium;c Department of Endocrinology, University Hospitals Leuven, Leuven, BelgiumView further author information

Gyorgy Bartfaid Department of Obstetrics, Gynaecology and Andrology, Albert Szent-Gyorgy Medical University, Szeged, HungaryView further author information

Felipe F. Casanuevae Department of Medicine, Santiago de Compostela University, Complejo Hospitalario Universitario de Santiago (IDIS), CIBER de Fisiopatología Obesidad y Nutricion (CB06/03), Instituto Salud Carlos III, Santiago de Compostela, SpainView further author information

Mario Maggif Endocrinology and Andrology Unit, “Mario Serio" Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyView further author information

Terence W. O’Neillg Centre for Epidemiology Versus Arthritis, The University of Manchester & NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UKView further author information

Margus Punabh Andrology Clinic, Tartu University Hospital, and Institute of Clinical Medicine, and Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, EstoniaView further author information

Giulia Rastrellif Endocrinology and Andrology Unit, “Mario Serio" Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, ItalyView further author information

Jolanta Slowikowska-Hilczeri Department of Andrology and Reproductive Endocrinology, Medical University of Łódź, Łódź, PolandView further author information

Jos Tournoyj Department of Geriatrics, University Hospitals Leuven, and Department of Public Health and Primary Care, KU Leuven, Leuven, BelgiumView further author information

Dirk Vanderschuerenb Department of Chronic Diseases and Metabolism, Laboratory of Clinical and Experimental Endocrinology, Leuven, KU, Belgium;c Department of Endocrinology, University Hospitals Leuven, Leuven, BelgiumView further author information

Frederick CW. Wuk Department of Endocrinology, Manchester University NHS Foundation Trust, Manchester, UKView further author information

Ilpo T. Huhtaniemil Institute of Reproductive and Developmental, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Campus, London, UKView further author information

Richard Ivella School of Biosciences, University of Nottingham, Sutton Bonington, UK;m School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, UKCorrespondence[email protected]
View further author information

show all

Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date